Transnasal Esophagoscopy (TNE) Esophageal Cancer Screening
Repurposing Transnasal Esophagoscopy: Targeting Interventions for a Community That Has Been Targeted for Cancer Risk
Sponsor: Cures Within Reach
Terminated
Transnasal Esophagoscopy (TNE) scope is no longer manufactured so the study is unable to be continued.
Other terminated trials from Cures Within Reach
Other Esophageal Cancer trials with similar outcome
Listed as NCT05480891, this observational or N/A phase trial focuses on Esophageal Cancer and remains terminated or withdrawn. Sponsored by Cures Within Reach, it has been updated 8 times since 2023, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
8 versions recorded-
Jun 2025 — Present [monthly]
Terminated
Status: Recruiting → Terminated
-
Sep 2024 — Jun 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jun 2024 — Jul 2024 [monthly]
Recruiting
-
Jun 2023 — Jun 2024 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Dec 2022 — Jun 2023 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Nov 2022 — Dec 2022 [monthly]
Not Yet Recruiting
-
Sep 2022 — Nov 2022 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Cures Within Reach
- University of Illinois at Chicago
For direct contact, visit the study record on ClinicalTrials.gov .